Managing biochemical recurrence (BCR) of localized prostate cancers (PCa) that have failed all options for local treatment has been the topic of an incommensurable number of manuscripts and opinion papers.
No takes yet. Share an insight, caveat, or question.
Achard et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: